Zofran Birth Defect Lawsuits Top 100 Nationwide
More than 100 lawsuits alleging that the GlaxoSmithKline anti-nausea medication Zofran is linked to an increased risk of birth defects have been filed around the country to date.
Wednesday, November 18, 2015 - More than 100 lawsuits have been filed in the Zofran birth defect litigation nationwide. The latest report from the multidistrict litigation relate to the allegations that Zofran is linked to birth defects listed 112 lawsuits filed connected to Zofran. Plaintiffs behind these lawsuits claim that GlaxoSmithKline's (GSK) anti-nausea medication Zofran has led to the development of birth defects in the children of mothers who are prescribed the drug during pregnancy.
The lawsuits, which have comes from more than a dozen states around the country, claim that GSK knew of the potential risks involved with their Zofran medication as it related to unborn babies but failed to affix a warning label to the bottles. This was only part of the issue however, as plaintiffs also took issue with the manufacturer's penchant for promoting off-label marketing to support the drug. The off-label marketing alleged by the plaintiffs occurs when a drug company encourages the prescription of a particular rug for uses that have not been approved by the FDA.
These off-label prescriptions are often sought by drug companies because it allows them to sell a drug without having to go through the FDA's stringent testing requirements. This allows a company such as GSk to advise doctors to prescribe Zofran to pregnant mothers to combat morning sickness without having the drug tested for that specific cause. That testing is important however, as the dangers that some drugs can pose necessitate that screening process to prevent what many have claimed happened wit Zofran.
Mothers across the nation have claimed that their children are being born with heart defects, club foot, malfunctioning organs, and a host of additional complications as a result of being prescribed Zofran while pregnant. The drug was intended to be used as an anti-nausea remedy for patients recovering from surgery or following chemotherapy treatments. However, because of off-labeling measures used by GSK, plaintiffs claim that their children were put at risk of unknown side effects that have taken the form of serious and sometimes fatal birth defects.
GSK has had a history of marketing drugs off-label to patients, and settled with the Department of Justice in 2012 for $3 billion that brought to an end a number of charges against the company including many off-label marketing claims. More than two decades of studies have been produced by medical journals, universities and newspaper that have found the increased risk of birth defects relate to Zofran can jump up to 30 percent when the drug is prescribed in the first trimester. The birth defects range from heart deformities, kidney failure, cleft lip, and a number of other serious problems allegedly caused by a fetus' exposure to Zofran in the womb.
The lawsuits were consolidated into multidistrict litigation in October with a motion to transfer that only included 12 separate lawsuits. Since that time, 100 additional suits have been filed with many more expected to be added in the coming weeks and months. The MDL is based in the District of Massachusetts federal court in Boston.
More Recent Zofran Birth Defects Lawsuit News:
- Australian Zofran Study Finds Increased Risk Of Birth Defects | 1/27/2016
- GSK Files To Dismiss All Zofran MDL Lawsuits | 1/20/2016
- Diversity In Severity Of Defects Allegedly Caused By Zofran | 1/13/2016
- Zofran MDL Lawsuits Top 200 Total | 1/6/2016
- Questions Of Fact In Zofran MDL Lawsuits | 12/30/2015
- Direct Filing Allowed In Zofran MDL | 12/23/2015
- Total Zofran Lawsuits Expected To Top 200 | 12/16/2015
- Idaho Lawsuit Claims GSK Didn't Test Zofran On Humans | 12/9/2015
- Doctors Still Able To Prescribe Zofran For Morning Sickness | 12/2/2015
- Updates for Zofran MDL Heading Into Month Two Of Consolidation | 11/25/2015
- New Zofran Lawsuit Filed In Idaho | 11/11/2015
- First Zofran Status Conference Set For November 17 | 11/4/2015
- New Alabama Zofran Lawsuit Filed | 10/28/2015
- Four Separate Plaintiffs File Zofran Claim Together | 10/21/2015
- Zofran Lawsuits Consolidated by JPML | 10/14/2015
- Oregon Family Files New Zofran Lawsuit | 10/7/2015
- Toronto Star Zofran Report Significant In Plaintiffs' Arguments | 9/30/2015
- Lawsuits Grow Nationwide As MDL Decision Nears | 9/16/2015
- Two New Zofran Lawsuits Claim Birth Defects From 1990's | 9/9/2015
- New Zofran Lawsuit Claims GSK Drug Led To Child's Single Kidney | 9/2/2015
- JPML Will Hear GSK Motion To Transfer In October | 8/26/2015
- Zofran Lawsuits Top 30 Nationwide As GSK Spokesperson Denies Liability | 8/19/2015
- Two New Zofran Lawsuits Filed In Illinois And North Dakota | 8/12/2015
- FDA Plans Public Meeting Regarding Off-Label Medication | 8/5/2015
- New Report Released Intended To Advise Potential Zofran Plaintiffs. | 7/29/2015
- New Zofran Lawsuits Filed In Alabama and Louisiana | 7/22/2015
- Zofran Lawsuits Expected To Rise After MDL Request | 7/15/2015
- GSK Files Motion To Transfer 12 Zofran Lawsuits Into MDL | 7/8/2015
- Research Linking Zofran and Birth Defects Prevalent Throughout US | 7/1/2015
- Families Around U.S. Filing Claims On Behalf Of Children Affected By Zofran | 6/22/2015
- New Zofran Lawsuit In Ohio Claims Drug Caused Death of Daughter | 6/14/2015
- Plaintiffs Continue To File New Zofran Lawsuits | 6/10/2015
- New Zofran Lawsuit Filed in Alabama | 4/9/2015
No-Cost, No-Obligation Zofran Birth Defect Lawsuit Case Review If You or a Loved One Has Had a Baby with Birth Defects
Onder, Shelton, O'Leary & Peterson, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O'Leary & Peterson has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation.